XML 107 R89.htm IDEA: XBRL DOCUMENT v3.24.0.1
Parent Only Condensed Financial Statements - Condensed Statements of Cash Flows (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:      
Net income $ 25,536 $ 26,645 $ 28,401
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Stock-based compensation 858 776 562
Benefit for deferred income taxes 110 224 1,465
Net cash provided by operating activities 27,852 24,194 42,855
Cash flows from financing activities:      
Cash dividend payments on common stock (5,657) (5,638) (5,757)
Proceeds from issuance of subordinated debt 0 0 34,299
Purchase and retirement of common stock 1 6,814 13,619
Proceeds from exercise of stock options 0 489 257
Net cash (used in) provided by financing activities (29,488) 41,105 415,471
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR 31,170    
CASH AND CASH EQUIVALENTS AT END OF YEAR 53,728 31,170  
Non-cash investing and financing activities:      
Proceeds from stock issued under employee stock purchase plan 206 216 204
Parent Company      
Cash flows from operating activities:      
Net income 25,536 26,645 28,401
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Undistributed net income of subsidiary, net of distributions (22,256) (66,583) (21,496)
Stock-based compensation 858 776 562
Amortization of Debt Issuance Costs 145 145 0
Net (increase) decrease in other assets (715) (499) 1
Net increase (decrease) in other liabilities (542) 390 307
Benefit for deferred income taxes 0 15 6
Net cash provided by operating activities 3,026 (39,111) 7,781
Cash flows used in investing activities:      
Investment in subsidiary 0 0 0
Cash flows from financing activities:      
Cash dividend payments on common stock (5,657) (5,638) (5,757)
Proceeds from issuance of subordinated debt 0 30,000 34,299
Purchase and retirement of common stock 1 6,814 13,619
Proceeds from exercise of stock options 0 489 256
Net cash (used in) provided by financing activities (5,452) 18,253 15,383
Increase (decrease) in cash and cash equivalents (2,426) (20,858) 23,164
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR 3,202 24,060 896
CASH AND CASH EQUIVALENTS AT END OF YEAR 776 3,202 24,060
Cash paid during the year for interest 4,180 1,431 119
Non-cash investing and financing activities:      
Proceeds from stock issued under employee stock purchase plan $ 206 $ 216 $ 204